The synthetic biology market is projected to reach USD 30.7 billion by 2026 from USD 9.5 billion in 2021, at a CAGR of 26.5% during the forecast period.
To know about the assumptions considered for the study download the pdf brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=889
The growth of this market is mainly driven by the increasing demand for synthetic genes and synthetic cells, a wide range of applications of synthetic biology, declining cost of DNA sequencing and synthesizing, increasing R&D funding and initiatives in synthetic biology, and increasing investments in the market.
Global Synthetic Biology Market Scope:
| Metrics | Details |
| Study Period | 2019–2026 |
| Market Size in 2025 | USD 30.7 Billion |
| Segment Covered | Tool, Technology, Application, and Region |
| by tool Covered | Oligonucleotides, Enzymes, Synthetic Cells |
| by technology Covered | Gene Synthesis, Genome Engineering |
| By Application Covered | Tissue Regeneration, Biofuel, Consumer Care, Food & Agriculture, Environmental |
| Regions Covered | North America, Europe, Asia Pacific, Middle East and Africa, and South America |
| Key Players Profiled | Thermo Fisher Scientific (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Novozymes A/S (Denmark), Ginkgo Bioworks (US), Amyris (US), Precigen (US), GenScript Biotech Corporation (China), Twist Bioscience (US), Synthetic Genomics (US), Codexis (US), Synthego (US), Creative Enzymes (US), Eurofins Scientific (Luxembourg) |
Thermo Fisher Scientific (US) held the leading position in the synthetic biology market. The company offers synthetic biology products, which include DNA fragments, software, engineering kits, DNA oligos, and clones. Its large share in this market can be attributed to its broad product portfolio, years of experience, and vast distribution channel.
Merck KGaA (Germany) provides a wide range of products as well as services in the market. Geographically, the company has its footprint in 65 countries across the globe and is further expanding its network. For instance, the company opened its largest M Lab Collaboration Center in Shanghai (China) to provide its drug development services to the growing pharmaceutical industry in Asia.
Click Here to Access a Free Sample Report of the Global Autoinjectors Market @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=889
Recent Developments
- In January 2021, Novozymes launched Frontia GlutenEx. It would help wheat processors increase their gluten protein recovery and, at the same time, cut down on energy consumption.
- In February 2021, Merck partnered with BioNTech (Germany) to supply lipids for the production of Pfizer-BioNTech COVID-19 Vaccine (BNT162b2).
- In January 2021, Merck acquired AmpTec (Germany). With this acquisition, the company strengthened its product portfolio to develop and manufacture mRNA for utilizing vaccines, treatments, and diagnostics.
Our Free Sample Report Consists of the following:
- Introduction, Overview, and in-depth industry analysis are all included in the 2022 updated report.
- The COVID-19 Pandemic Outbreak Impact Analysis is included in the package
- About 220+ Pages Research Report (Including Recent Research)
- Provide detailed chapter-by-chapter guidance on Request
- Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2022
- Includes Tables and figures have been updated
- The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
Directly Purchase a copy of the report [377] @ https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=889
